{"id":358030,"date":"2023-05-17T13:05:09","date_gmt":"2023-05-17T11:05:09","guid":{"rendered":"https:\/\/medizinonline.com\/carcinoma-da-mama-com-metastases-osteoblasticas-disseminadas\/"},"modified":"2023-05-17T13:07:56","modified_gmt":"2023-05-17T11:07:56","slug":"carcinoma-da-mama-com-metastases-osteoblasticas-disseminadas","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/carcinoma-da-mama-com-metastases-osteoblasticas-disseminadas\/","title":{"rendered":"Carcinoma da mama com met\u00e1stases osteobl\u00e1sticas disseminadas"},"content":{"rendered":"\n<p><strong>Mais de 70% dos doentes com cancro da mama s\u00e3o diagnosticados como receptores hormonais positivos e HER2 negativos (HR+\/HER2-) [1]. [2-5]Os dados de ensaios cl\u00ednicos mostram que uma combina\u00e7\u00e3o terap\u00eautica com inibidores CDK4\/6 pode aumentar a sobreviv\u00eancia sem progress\u00e3o (PFS) e a sobreviv\u00eancia global (OS). Foi tamb\u00e9m o que aconteceu no caso apresentado de uma doente de 81 anos com carcinoma da mama HR+\/HER2- recorrente.<\/strong><\/p>\n\n<!--more-->\n\n<p>Veja todos os pormenores do caso apresentado pelo Dr. Marcus Vetter, do Centro de Oncologia e Hematologia do Hospital Cantonal de Baselland, no v\u00eddeo.<\/p>\n\n<p><\/p>\n\n<figure class=\"wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Vetter_DE_FINAL\" data-src=\"https:\/\/player.vimeo.com\/video\/814171020?h=cd373566bd&amp;dnt=1&amp;app_id=122963\" width=\"1160\" height=\"653\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe>\n<\/div><\/figure>\n\n<p>Refer\u00eancias<\/p>\n\n<p>Blows, F.M., et al, <em>Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies<\/em>. PLoS Med, 2010. <strong>7<\/strong>(5): p. e1000279.<\/p>\n\n<p>2 Goyal, R.K., et al, <em>Overall survival associated with CDK4\/6 inhibitors in patients with HR+\/HER2- metastatic breast cancer in the United States: A SEER-Medicare population-based study<\/em>. Cancer, 2023. <strong>129<\/strong>(7): p. 1051-1063.<\/p>\n\n<p>Goyal, R.K., et al, <em>Impact of CDK4\/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+\/HER2- metastatic breast cancer in the United States [Impacto dos inibidores CDK4\/6 na utiliza\u00e7\u00e3o da quimioterapia em linhas terap\u00eauticas anteriores para o cancro da mama metast\u00e1tico HR+\/HER2- nos Estados Unidos].<\/em> Breast Cancer Res Treat, 2023. <strong>198<\/strong>(1): p. 159-166.<\/p>\n\n<p>4. Li, J., et al, <em>Cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer: a meta-analysis of randomized clinical trials.<\/em>Breast Cancer Res Treat, 2020. <strong>180<\/strong>(1): p. 21-32.<\/p>\n\n<p>Elfgen, C. e V. Bjelic-Radisic, <em>Targeted Therapy in HR+ HER2- Metastatic Breast Cancer: Current Clinical Trials and Their Implications for CDK4\/6 Inhibitor Therapy and beyond Treatment Options.<\/em>Cancers (Basel), 2021. <strong>13<\/strong>(23).<\/p>\n\n<p>As refer\u00eancias est\u00e3o dispon\u00edveis mediante pedido.<\/p>\n\n<p>Pode encontrar as informa\u00e7\u00f5es t\u00e9cnicas actuais sobre a Ibrance\u00ae em<a> www.swissmedicinfo.ch.<\/a> <\/p>\n\n<p>PP-IBR-CHE-0423 Abril de 2023<\/p>\n\n<p>Contribui\u00e7\u00e3o em linha desde 17.05.2023<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mais de 70% dos doentes com cancro da mama s\u00e3o diagnosticados como receptores hormonais positivos e HER2 negativos (HR+\/HER2-) [1]. [2-5]Os dados de ensaios cl\u00ednicos mostram que uma combina\u00e7\u00e3o terap\u00eautica&hellip;<\/p>\n","protected":false},"author":14,"featured_media":355334,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Caso do paciente ","footnotes":""},"category":[11339,11379,11551],"tags":[],"powerkit_post_featured":[],"class_list":["post-358030","post","type-post","status-publish","format-standard","has-post-thumbnail","category-conteudo-do-parceiro","category-oncologia-pt-pt","category-rx-pt","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-06 18:11:07","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":358028,"slug":"carcinoma-de-mama-con-metastasis-osteoblastica-diseminada","post_title":"Carcinoma de mama con met\u00e1stasis osteobl\u00e1stica diseminada","href":"https:\/\/medizinonline.com\/es\/carcinoma-de-mama-con-metastasis-osteoblastica-diseminada\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/358030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=358030"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/358030\/revisions"}],"predecessor-version":[{"id":358035,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/358030\/revisions\/358035"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/355334"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=358030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=358030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=358030"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=358030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}